Finished Dose

Within our dedicated development centre, we now have a large capacity for cGMP production of solid, non-sterile liquid and semi-solid formulations. The cGMP facility gives us flexibility to manufacture small Phase I batches through to larger Phase III batches.


We offer a scaleable solution for clinical batch manufacture, and use our wealth of experience to assist clients with identifying the appropriate sized production lines to meet their objectives. We’re not constrained by scale, engaging in projects of all sizes, including contract manufacturing for companies that have development capabilities in-house but not the ability to carry out clinical batches. We are very flexible in our approach and work around our customer’s needs.

New development facility now open for formulation development and clinical manufacture services. Interested to find out more? Contact us


How Aesica can add value at every stage

Finished dose manufacture – API development – API manufacture